Dissolution Improvement and the Mechanism of the Improvement from Cocrystallization of Poorly Water-soluble Compounds

PurposeTo demonstrate improvement in the dissolution of exemestane and megestrol acetate from cocrystallization using various particle sizes and to investigate the mechanism of the improved dissolution.MethodsCocrystal screening was performed by slurry crystallization. The cocrystals were identified and characterized by powder X-ray diffraction, thermal analysis, and single crystal X-ray diffraction. Different particle sizes of each cocrystal were prepared from organic solutions. Solubility and dissolution rates were evaluated using dissolution tests. Transformation behavior of the cocrystals in suspension was analyzed by PXRD and polarization microscopy.ResultsTwo novel cocrystals were obtained: exemestane (EX)/maleic acid (MAL) (cocrystal 1) and megestrol acetate (MA)/saccharin (SA) (cocrystal 2). Cocrystal 1 showed a high dissolution rate even with large particles. Cocrystal 2 showed supersaturation with fine particles. The transformation from cocrystal 1 to EX was observed within 1 min in suspension. Cocrystal 2 was transformed to MA within 2–4 h.ConclusionsCocrystallizations of EX and MA improved initial dissolution rates compared to the respective original crystals. The mechanism of dissolution enhancement varied. With cocrystal 1, fine particle formation resulted in enhancement, whereas with cocrystal 2, enhancement was due to the maintenance of the cocrystal form and rapid dissolution before transformation to the original crystal.

[1]  Ping Gao,et al.  Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations , 2004, Drug development and industrial pharmacy.

[2]  Gloria Kwei,et al.  Regiospecific Intestinal Absorption of the HIV Protease Inhibitor L-735,524 in Beagle Dogs , 1995, Pharmaceutical Research.

[3]  M. Schuster,et al.  Megestrol acetate in cachexia and anorexia , 2006, International journal of nanomedicine.

[4]  Siling Wang,et al.  Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization. , 2007, International journal of pharmaceutics.

[5]  Stephen R Byrn,et al.  Designing a molecular delivery system within a preclinical timeframe. , 2007, Drug discovery today.

[6]  N. Rasenack,et al.  Dissolution Rate Enhancement by in Situ Micronization of Poorly Water-Soluble Drugs , 2002, Pharmaceutical Research.

[7]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[8]  N. Rodríguez-Hornedo,et al.  Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies. , 2007, Journal of pharmaceutical sciences.

[9]  V. Lehto,et al.  Does the preferred orientation of crystallites in tablets affect the intrinsic dissolution? , 2007, Journal of pharmaceutical and biomedical analysis.

[10]  C. Lipinski.  Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[11]  Jeanette T. Dunlap,et al.  Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids. , 2004, Journal of the American Chemical Society.

[12]  Geoff G. Z. Zhang,et al.  Efficient co-crystal screening using solution-mediated phase transformation. , 2007, Journal of pharmaceutical sciences.

[13]  A. Serajuddin,et al.  Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine. , 1985, Journal of pharmaceutical sciences.

[14]  W. Motherwell,et al.  Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.

[15]  Matthew L Peterson,et al.  Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential. , 2007, Molecular pharmaceutics.

[16]  Aeri Park,et al.  The salt-cocrystal continuum: the influence of crystal structure on ionization state. , 2007, Molecular pharmaceutics.

[17]  Tony Auffret,et al.  Quantifying solubility enhancement due to particle size reduction and crystal habit modification: case study of acetyl salicylic acid. , 2007, Journal of pharmaceutical sciences.

[18]  S. Yalkowsky,et al.  Handbook of aqueous solubility data , 2003 .

[19]  Yukihiko Suzuki,et al.  The thermal behaviour of dicarboxylic acids in various atmospheres , 1994 .

[20]  Cornelia M Keck,et al.  Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles. , 2004, Journal of biotechnology.

[21]  Sarah J. Nehm,et al.  Reaction crystallization of pharmaceutical molecular complexes. , 2006, Molecular pharmaceutics.

[22]  R. Chokshi,et al.  Improving the Dissolution Rate of Poorly Water Soluble Drug by Solid Dispersion and Solid Solution—Pros and Cons , 2007, Drug delivery.

[23]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[24]  Susan Budavari,et al.  The Merck index , 1998 .

[25]  K. Terada,et al.  Cocrystal Screening of Stanolone and Mestanolone Using Slurry Crystallization , 2008 .

[26]  Maria Cristina Burla,et al.  SIR92 – a program for automatic solution of crystal structures by direct methods , 1994 .

[27]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[28]  Yukihiko Suzuki,et al.  Thermal behaviour of dicarboxylic acids. Determination of melting points by DTA , 1992 .

[29]  Elaine Merisko-Liversidge,et al.  Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  R. Femia,et al.  The science of megestrol acetate delivery: potential to improve outcomes in cachexia. , 2005, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[31]  S. Velaga,et al.  Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization , 2008, Pharmaceutical Research.

[32]  Ning Li,et al.  Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process. , 2006, Die Pharmazie.

[33]  D. Lake,et al.  Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer , 2008, Breast Cancer Research and Treatment.

[34]  Sarah J. Nehm,et al.  Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation , 2006 .

[35]  Chong-K. Kim,et al.  A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Kiyohiko Sugano,et al.  Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test , 2006, Pharmaceutical Research.

[37]  A Farinha,et al.  Improved Bioavailability of a Micronized Megestrol Acetate Tablet Formulation in Humans , 2000, Drug development and industrial pharmacy.

[38]  Jae-Young Jung,et al.  Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. , 1999, International journal of pharmaceutics.

[39]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[40]  Orn Almarsson,et al.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids. , 2003, Journal of the American Chemical Society.

[41]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .